REGENERON PHARMACEUTICALS: New Slide Deck Published
Trending News 🌥️ Regeneron Pharmaceuticals($NASDAQ:REGN) recently published a slide deck in conjunction with an event. Some key points from the [...]
Regeneron Pharmaceuticals to Present at ESMO 2022 Investor Event
Trending News 🌥️ Regeneron Pharmaceuticals($NASDAQ:REGN), Inc will present at the ESMO 2022 Investor Event on September 12, 2022. The event [...]
REGENERON PHARMACEUTICALS: From Research to Reality
Trending News 🌥️ REGENERON($NASDAQ:REGN) Pharmaceuticals is a research-based biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of [...]
New WHO guidelines recommend monoclonal antibodies Inmazeb and Ebanga for the treatment of Ebola.
Trending News ☀️ The World Health Organization has announced the publication of new guidelines on the use of monoclonal antibodies [...]
REGENERON PHARMACEUTICALS Q2 RESULTS BEAT EXPECTATIONS
Trending News ☀️ According to Regeneron Pharmaceuticals’ ($NASDAQ:REGN) press release, the company’s Q2 non-GAAP EPS of $9.77 beats expectations by [...]
